The third dose of the Covid-19 vaccine can increase antibodies to the virus in organ transplant patients.
In a study conducted in the USA, it was observed that the antibody level increased only after the third dose of the new type of corona virus (Covid-19) vaccine was administered in some patients who underwent organ transplants.
According to the study published in the Annals of Internal Medicine, scientists from John Hopkins University in the USA examined the effect of the third dose of Covid-19 vaccine on the body’s antibody production in organ transplant patients.
In the study, two doses of Covid-19 vaccine were administered to 30 patients who underwent organ transplants. It was observed that 24 of these patients did not produce antibodies, and 6 of them produced low levels of antibodies.
All patients received the third dose of vaccine 67 days later.
While more antibody production was observed in 6 patients with low levels of antibody production in the first two doses, 8 of 24 patients who did not produce antibodies against the virus produced antibodies after the third dose of vaccine.
Thus, after the third dose of vaccine, the number of people who produced antibodies against Covid-19 in 30 patients increased from 6 to 14.
Conducting the study from John Hopkins University, Dr. Dorry Segev said the study is “promising” in terms of increasing antibody production in transplant patients.
In organ transplant patients, immunosuppressive drugs are given to the patients so that the body does not reject the transplanted organ, which makes the patients vulnerable to the Covid-19 outbreak.